Why did Zydus Wellness (ZYDUSWELL) stock move recently?

On 8/5/2026, Zydus Wellness moved -3.6% — Zydus Wellness shares fell after the company reported Q1FY27 consolidated net profit declining 7% YoY to ₹118.9 crore, despite strong revenue growth. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Zydus Wellness (ZYDUSWELL) overvalued or fairly valued?

MarketChacha shows Zydus Wellness's valuation in context — a forward P/E of about 31.7, a price-to-book of about 2.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Zydus Wellness's revenue?

Zydus Wellness reported revenue of ₹3,961 Cr for FY2026, with net profit of ₹197 Cr, per official filings.

What is the share price of Zydus Wellness (ZYDUSWELL)?

Zydus Wellness last traded at ₹506.10 (-5.2% on the day), as of 8/11/2026 — a delayed quote shown for education, not investment advice.

Zydus Wellness

ZYDUSWELL · NSE · FMCG · India

Snapshot

TickerZYDUSWELL

ExchangeNSE

SectorFMCG

IndustryPackaged Foods

CountryIndia

Employees1,685

HeadquartersAhmedabad, India

Websitewww.zyduswellness.com

Filings tracked4

About Zydus Wellness

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in Asia, the Middle East, Africa, the Oceania, Europe, and North America. It provides glucose powder under the Glucon-D brand; sugar substitute products under the Sugar Free Gold+, Sugar Free Natura, Sugar Free Green, and I'm lite brands; Milk-based nutrition drink products under the Complan brand; table spreads under the Nutralite brand; skin cleansing products under the Everyuth brand; hair color products under the Cuticolor brand; heat powder under the Nycil brand; and healthy eating products, such as snack bars, protein bars, breakfast cookies, and protein chips under the RiteBite brand. The company also offers plant-based supplements, vitamins and minerals, collagens, omegas, probiotics, and micronutrients for adults under the WeightWorld brand; health and wellness products, including multivitamin and vitamin D3 gummies, mushroom-based supplements, and other superfood supplements under the MaxMedix brand; and food supplements for dogs and cats under the Animigo brand. The company was formerly known as Carnation Nutra-Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is headquartered in Ahmedabad, India. Zydus Wellness Limited operates as a subsidiary of Zydus Lifesciences Limited.

Who owns it

Promoters69.8%
Institutions20.9%
Public & other9.2%

44 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 8.8 points over the period — profitability is trending down.

Net margin trend13.8% → 5.0%

Margin has compressed by about 8.8 points over the period — profitability is trending down.

Growth qualityrev 21% · PAT -14%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹1,127 Cr · EPS 1.20

Est. earnings growth +213.7%

Next fiscal year

Rev ₹6,082 Cr · EPS 15.96

Est. earnings growth +29.0%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 5

Revenue (FY2026)

₹3,961 Cr

Net margin

5.0%

Revenue CAGR (3y)

+20.7%

Profit CAGR (3y)

-14.0%

Net profit (FY2026)

₹197 Cr

Ask MarketChacha about ZYDUSWELL

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Aug 5, 2026
Zydus Wellness shares fell after the company reported Q1FY27 consolidated net profit declining 7% YoY to ₹118.9 crore, despite strong revenue growth.
source 1 ↗source 2 ↗source 3 ↗· confidence: high
Jul 29, 2026
No specific catalyst identified for the 5.46% rise; the stock moved with broader market or sector trends following the nine monthly results announced two days prior.
· confidence: low
Jul 23, 2026
Zydus Wellness shares fell with no identifiable company-specific catalyst from recent filings or news; the decline appears to reflect broader market or sector movement.
· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹3,961 Cr	₹197 Cr	5.0%
FY2025	₹2,709 Cr	₹347 Cr	12.8%
FY2024	₹2,328 Cr	₹267 Cr	11.5%
FY2023	₹2,255 Cr	₹310 Cr	13.8%

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹1,437 Cr	₹119 Cr	8.3%
Q4 FY26	₹1,485 Cr	₹162 Cr	10.9%
Q3 FY26	₹965 Cr	₹-40 Cr	-4.1%
Q2 FY26	₹651 Cr	₹-53 Cr	-8.1%
Q1 FY26	₹861 Cr	—	—

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

ESG Rating
ESG rating received from Crisil
BSE8/8/2026
Investor Presentation
Investor presentation
BSE8/4/2026
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
BSE8/4/2026
Unaudited Financial Results For The Quarter Ended On June 30, 2026
Unaudited financial results for the quarter ended on June 30, 2026
BSE8/4/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.